chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Interstitial lung disease, Intervertebral disc degeneration, Left atrial dilatation, Liver function test, Lung consolidation
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Mitral valve calcification, Mitral valve incompetence, Multipathogen PCR test, Peripheral swelling
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Procedural complication, Prohormone brain natriuretic peptide increased, Pulmonary congestion, Pulmonary fibrosis, Pyrexia
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Renal atrophy, Renal impairment, Respiratory syncytial virus test negative, Right atrial dilatation, Right ventricular dilatation
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Right ventricular dysfunction, SARS-CoV-2 test positive, Scan with contrast abnormal, Sputum culture, Tachypnoea
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Tricuspid valve incompetence, Troponin increased, Ventilation/perfusion scan, White blood cell count increased
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 35.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Blood test
Clinical narrative: Widespread alopecia. Alopecia areata all over the entire body. Large patches of hair falling out on scalp, eyebrows, eyelashes, arms, legs, chest, etc. Rapid hair loss - diagnosed as alopecia areata/telogen effluvium - possible alopecia universalis onset. No prior history of chronic alopecia before vaccine doses 1 and 2.   Small patches developed on scalp after first shot, then after the second shot, a few days later, massive shedding all over body and face. Beard patches, and eyebrows thinning. Has progressed dramatically in the past several months.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: patient developed swelling around eyes and a small rash on the face that was resolved with one dose of diphenhydramine 25 mg.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Loss of consciousness
Clinical narrative: Frequent HA's and passed out 1/31/22
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: NO ADVERSE EVENT; FACILITY NOTIFIED THE PATIENT WAS 17 YEARS OLD AT TIME OF ADMINISTRATION REQUIRING A VAERS REPORT
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Computerised tomogram abdomen, Computerised tomogram pelvis, Condition aggravated
Clinical narrative: Developed symptoms two weeks later 12/01/2021, Acute lower back pain and inflammation, lasted two weeks 01/10/2022 developed left and right elbow joint pain. Recovered from back pain; however, not from the elbow joint pain in the left and right elbow joint. Still under going treatment for the elbow joint pain issues. Dr. visit for back pain 12/16/2021.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Pain
Clinical narrative: Developed symptoms two weeks later 12/01/2021, Acute lower back pain and inflammation, lasted two weeks 01/10/2022 developed left and right elbow joint pain. Recovered from back pain; however, not from the elbow joint pain in the left and right elbow joint. Still under going treatment for the elbow joint pain issues. Dr. visit for back pain 12/16/2021.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: The patient reported to me in a televisit, the event which occurred on 12/13/2021. She received the booster, Pfizer that morning at local hospital. She sees me for her MS. She went back to work at noon the same day as the COVID booster and then she was found down by her colleagues at work at 3pm. No one is certain what happened prior to finding her down. No evidence for seizures, though this cannot be ruled out. She was admitted to local Hospital and had extensive workup from there. I am working to get records from that hospital stay. She notes no conclusion exactly was made from that workup other then an adverse reaction to the booster. You may want additional information from those hospital records.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Confusional state, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Within 30 minutes to about 1 hour after receiving the vaccine, I mentioned to my boyfriend that it was so strange that I was having trouble breathing, I wasn't aware that this was a known reaction. When I come in contact with gluten from cross-contamination I take Benadryl, as the breathing was becoming labored, my stomach became distended and my fingers became swollen. As soon as my fingers started swelling up I took 2 servings of Benadryl and within 30 minutes my breathing was improving and my joints had marked improvement from pain within 3 days. I continued taking Benadryl for the next three days. I basically feel like the vaccine put me into a flare, which I had been concerned about as my joints do swell up from time to time. The lack of breathing was scary, it felt like being at 10,000 ft in altitude without adjusting. I was also light headed and confused and tired for those three days but only had expected pain at the injection site. I am still feeling a little confusion which is typical for me in a flare up, so I'm hoping that goes away soon.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fear, Gastric dilatation, Injection site pain, Peripheral swelling, Vaccination complication
Clinical narrative: Within 30 minutes to about 1 hour after receiving the vaccine, I mentioned to my boyfriend that it was so strange that I was having trouble breathing, I wasn't aware that this was a known reaction. When I come in contact with gluten from cross-contamination I take Benadryl, as the breathing was becoming labored, my stomach became distended and my fingers became swollen. As soon as my fingers started swelling up I took 2 servings of Benadryl and within 30 minutes my breathing was improving and my joints had marked improvement from pain within 3 days. I continued taking Benadryl for the next three days. I basically feel like the vaccine put me into a flare, which I had been concerned about as my joints do swell up from time to time. The lack of breathing was scary, it felt like being at 10,000 ft in altitude without adjusting. I was also light headed and confused and tired for those three days but only had expected pain at the injection site. I am still feeling a little confusion which is typical for me in a flare up, so I'm hoping that goes away soon.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Bone pain, Headache, Injection site pain, Pain
Clinical narrative: About 3 hours in (2/2), upper arm hurt at injection site. By 11 pm on 2/2, pain was very bad. Took usual Atenolol at bedtime; also took 1 Tylenol at bedtime for the pain, which didn't provide any relief. Slept poorly. Around 4 am I had bone-crushing pain throughout my body, plus even worse pain from the tips of my fingers of my left hand through my torso. Was afraid I was having heart problems from the vaccine. By morning, temperature was 99.7 and resting pulse was 99. Temperature increased to 100.7 and stayed between 100.3 and 100.9 all day. Pulse stayed between 95 and 99 all day. Took Atenolol and Tylenol again before bedtime 2/3. Woke up 2/4 with a headache but pulse had dropped to 68 and temperature was normal. Arm still hurts but not as badly and mostly between elbow and shoulder and still achy all over. (I had a similar increase in pulse and temperature with the first two doses. Arm pain was more isolated.)
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality sleep
Clinical narrative: About 3 hours in (2/2), upper arm hurt at injection site. By 11 pm on 2/2, pain was very bad. Took usual Atenolol at bedtime; also took 1 Tylenol at bedtime for the pain, which didn't provide any relief. Slept poorly. Around 4 am I had bone-crushing pain throughout my body, plus even worse pain from the tips of my fingers of my left hand through my torso. Was afraid I was having heart problems from the vaccine. By morning, temperature was 99.7 and resting pulse was 99. Temperature increased to 100.7 and stayed between 100.3 and 100.9 all day. Pulse stayed between 95 and 99 all day. Took Atenolol and Tylenol again before bedtime 2/3. Woke up 2/4 with a headache but pulse had dropped to 68 and temperature was normal. Arm still hurts but not as badly and mostly between elbow and shoulder and still achy all over. (I had a similar increase in pulse and temperature with the first two doses. Arm pain was more isolated.)
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash erythematous
Clinical narrative: swollen tender R axillary with erythematous rash spreading to the R side of the chest with no pruritic, warmth, or pain.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Blister, Facial pain, Injection site pain, Musculoskeletal pain
Clinical narrative: Pain at injection site, chin, neck, shoulder blades, and wrist. Rash/blisters appeared under arm; was treated with steroid cream.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Neck pain, Rash
Clinical narrative: Pain at injection site, chin, neck, shoulder blades, and wrist. Rash/blisters appeared under arm; was treated with steroid cream.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Hypersomnia, Laboratory test, Magnetic resonance imaging, Physical examination
Clinical narrative: slept for 36 hours after vaccine very deep sleep a few weeks later began having ringing in right ear and significant vertigo - did not initially link to vaccine
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: slept for 36 hours after vaccine very deep sleep a few weeks later began having ringing in right ear and significant vertigo - did not initially link to vaccine
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Cardiogenic shock, Encephalopathy, Endotracheal intubation
Clinical narrative: Patient received Pfizer COVID vaccine on 1/29/21 and 2/20/21. On 2/2/22, patient had v. fib arrest at  home (intubated in the field) and admitted to our CCU with acute hypoxic respiratory failure, acute encephalopathy, cardiogenic shock, and GI bleed. Patient was also tested positive for COVID during admission. As of today (2/4/22), patient is still admitted in CCU intubated.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal haemorrhage, Intensive care, SARS-CoV-2 test positive, Ventricular fibrillation
Clinical narrative: Patient received Pfizer COVID vaccine on 1/29/21 and 2/20/21. On 2/2/22, patient had v. fib arrest at  home (intubated in the field) and admitted to our CCU with acute hypoxic respiratory failure, acute encephalopathy, cardiogenic shock, and GI bleed. Patient was also tested positive for COVID during admission. As of today (2/4/22), patient is still admitted in CCU intubated.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Patient experienced "tingling feeling throughout body, like a wave" 13 minutes into monitoring after vaccination.  *Patient stated she has HBP and had not taken her medication for 3 days  * 3:30pm BP taken by RN, L arm 260/140, Pulse- 100, Resp- 18  *3:34pm BP taken by RN, R arm 232/138, Pulse- 80, Resp- 16  *Dr. in at 3:38pm  *BP taken by RN with different cuff. L arm 228/122 R arm 218/118  *AUSC, Heart & Lungs  *Denies H/A, SOB, Chest Pain  *Dr. offered to call ambulance. Pt refused and stated she was going to see her personal MD, today. (at that moment)  *Pt escorted to her vehicle by Dr.   RPh 1/31/22 4:45pm
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Fall, Generalised tonic-clonic seizure, Head injury, Lethargy
Clinical narrative: Post-immunization, within a few minutes of administration, client fell forward out of chair, hit head, and had a tonic-clonic seizure lasting approximately 5 seconds. He resumed consciousness, and remained in confused, lethargic postictal state, with stable vital signs, until EMS arrived and transported him to the emergency room. Mother called later that afternoon to report that client was discharged from the ER, remained lethargic, but had not had any subsequent seizure activity at the time of the phone call.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Death occurred on 01/14/2022, tested positive for COVID-19 post-mortem on 01/14/2022, had been exposed to COVID-19 in household for 3+ weeks, received booster vaccination on 01/11/2022 (had NO prior COVID-19 vaccinations).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Musculoskeletal chest pain, Neoplasm malignant, Ulcer haemorrhage
Clinical narrative: Started feeling pain in left ribs and chest. Developed bleeding ulcer in November, then admitted to hospital and was hospitalized for 2 days where they found out he had cancer. Had a biopsy a week after and saw his Oncologist the next week. Ended up finding out that he has Liver Cancer. The Oncologist gave him a permanent prescription to take Chemo medication. Participant doesn't think that he had cancer before this and wonders if the vaccine accelerated his condition.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: covid pna
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast swelling, Breast tenderness, Diarrhoea, Dizziness, Erythema
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling hot, Hypoaesthesia oral, Injection site pain, Interchange of vaccine products
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Oedema peripheral, Pain, Peripheral swelling, Tenderness
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast swelling, Breast tenderness, Diarrhoea, Discomfort, Dizziness
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry throat, Erythema, Fatigue, Feeling hot, Hypoaesthesia oral
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Injection site pain, Interchange of vaccine products, Nausea, Oedema peripheral
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Pain, Peripheral swelling, Pruritus, Sacral pain
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin warm, Swelling, Tenderness, Throat irritation, Throat tightness
Clinical narrative: She developed redness and swelling on the upper deltoid muscle, large amounts of diarrhea, throat felt intermittent "funny like it is touching itself".  She was evaluated by allergy and was recommended to get the Janssen Covid 19 vaccine under close observation in hospital/ED. She received the vaccine on October 4, 2021. She had initial tight fuzzy dry throat with numb tongue within 20 minutes but never developed breathing concerns or coughs.  Pain below the injection site, after discharge she became dizzy, body aches, fatigue, and a sense that she was feverish, but did not get a fever. She has nausea on the first day of the injection.  Yesterday she woke up with her left arm, armpit, and left breast swollen and tender. She notes this has decreased but her arm and armpit is tender and swollen. She notes that the Tagamet has helped, she has not had any nausea or diarrhea.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthma, Chest pain, Dyspnoea, Incorrect dose administered, SARS-CoV-2 test
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthma, Blood creatinine, Blood immunoglobulin E, Blood thyroid stimulating hormone, Brain natriuretic peptide
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardiac stress test, Chest pain, Computerised tomogram, Computerised tomogram thorax, Differential white blood cell count
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Electrocardiogram, Extra dose administered, Fibrin D dimer
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Glomerular filtration rate, Laboratory test, Oxygen saturation decreased, Scan with contrast
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Speech disorder, White blood cell count
Clinical narrative: At approximately 1617 it was brought to the charge nurse's attention that an employee receiving their COVID-19 Pfizer booster received a second dose and not the flu vaccine. When asked how the incident occurred, the LVN stated when the employee sat down and handed over her Clinic Events sheet both flu and COVID were circled which indicates the employee is there for both vaccines. She stated she asked the employee if she was getting flu and the COVID vaccine and the employee stated yes. The LVN proceeded with the COVID questionnaire/consent. The employee signed the consent and the COVID vaccination was administered. After the administration the LVN told the employee she would then be receiving the flu vaccine. It was at this point that the employee stated they had just received COVID vaccine a few minutes earlier. The employee stated she did not dispute the question about receiving the flu and COVID vaccine because she was in the vaccine clinic to receive the vaccine and she didn't notice the questions were the same as the COVID questionnaire/consent she had just reviewed and signed. She was asked to wait for 30 minutes for monitoring and stated she was unable to stay. When she left the vaccination clinic, she was not experiencing any adverse side effects.
Age: 0.75
Sex: F
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Health Technician, administered Kinrix to patient who is 9 months old. Kinrix is labelled for those patients 4-6 years old. Patient's mother contacted. No harm caused.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Blood test
Clinical narrative: Received booster shot on 12/30/2021 and started to have symptoms of bells palsy on 1/26/2022. Went to family doctor and was prescribed medication.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune haemolytic anaemia, Fatigue, Haemoglobin decreased, Hypotension, Malaise
Clinical narrative: Covid vaccine booster on 12/29/2021, previous two Moderna vaccines were March 31, 2021 and April 2021.  Patient admitted to the hospital on 2/1/2022.  She presented with tachycardia, fatigue/malaise, hypotension and found with hemoglobin of 6.3 g/dl.  Diagnosis is autoimmune warm antibody hemolytic anemia
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Warm type haemolytic anaemia
Clinical narrative: Covid vaccine booster on 12/29/2021, previous two Moderna vaccines were March 31, 2021 and April 2021.  Patient admitted to the hospital on 2/1/2022.  She presented with tachycardia, fatigue/malaise, hypotension and found with hemoglobin of 6.3 g/dl.  Diagnosis is autoimmune warm antibody hemolytic anemia
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Malaise, Vomiting
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. Feeling unwell upon waking in the morning at 6:15. Vomiting around 7:30 am and tiredness and decreased appetite until around 9:00 am. Feeling recovered around 10:00 am/12:00 pm.